These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14139291)

  • 1. PROLONGED AMENORRHEA FOLLOWING MEDROXYPROGESTERONE.
    RUBIN A
    Am J Obstet Gynecol; 1964 Apr; 88():1092-3. PubMed ID: 14139291
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE USE OF 6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE (M.A.P.) IN OBSTETRICS IN ITS REPERCUSSIONS ON FETUSES OF THE FEMALE SEX].
    DESTRO F; PAOLINA L
    Minerva Ginecol; 1964 Jun; 16():520-5. PubMed ID: 14190021
    [No Abstract]   [Full Text] [Related]  

  • 3. TREATMENT OF THREATENED ABORTION WITH 6-METHYL-17-ACETOXYPROGESTERONE. PRELIMINARY REPORT ON A DOUBLE-BLIND CONTROLLED STUDY.
    Moller KJ; Bojsen-Moller B; Fuchs F; Villumsen A
    Acta Obstet Gynecol Scand; 1964; 42(S6):124-5. PubMed ID: 14151815
    [No Abstract]   [Full Text] [Related]  

  • 4. TREATMENT OF THREATENED PREMATURE LABOUR WITH 6-ALFA-METHYL-17-ALFA-ACETOXYPROGESTERONE (PERLUTEX LEO).
    Ovlisen B; Iversen J
    Acta Obstet Gynecol Scand; 1964; 42(S6):126-7. PubMed ID: 14151816
    [No Abstract]   [Full Text] [Related]  

  • 5. THE EFFECT OF TREATMENT OF ABORTION-PRONE WOMEN WITH SECROSTERON AND PROVERA.
    Krieger VI
    Aust N Z J Obstet Gynaecol; 1963 Sep; 3(3):129-31. PubMed ID: 14065030
    [No Abstract]   [Full Text] [Related]  

  • 6. PROGESTERONE AND 6-METHYL-17-ACETOXYPROGESTERONE IN THREATENED ABORTION AND PREMATURE LABOUR.
    FUCHS F
    Minerva Ginecol; 1965 Jan; 17():SUPPL:67-70. PubMed ID: 14304426
    [No Abstract]   [Full Text] [Related]  

  • 7. [TREATMENT OF THREATENED AND HABITUAL ABORTION WITH MEDROXYPROGESTERONE].
    BERARD MJ
    Can Med Assoc J; 1964 Aug; 91(5):212-8. PubMed ID: 14178406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PROGESTATIONAL HORMONES AND OTHER COMPOUNDS IN THE TREATMENT OF ABORTION. COMPARATIVE STUDY].
    SOARESFILHO A; BOCIKS J
    Minerva Ginecol; 1963 Aug; 15():836-8. PubMed ID: 14086252
    [No Abstract]   [Full Text] [Related]  

  • 9. CERVICAL MUCUS AND THE MANAGEMENT OF ABORTION.
    MACDONALD RR
    J Obstet Gynaecol Br Commonw; 1963 Aug; 70():580-92. PubMed ID: 14078542
    [No Abstract]   [Full Text] [Related]  

  • 10. [PROLONGED RESPIRATORY ARREST AS A RESULT OF ACUTE PACHYCARPINE POISONING].
    SKUTELSKII NM
    Sov Med; 1963 Nov; 27():112-3. PubMed ID: 14137976
    [No Abstract]   [Full Text] [Related]  

  • 11. EXPERIENCE WITH MEDROXY-PROGESTERONE ACETATE IN THE CONTROL OF THREATENED LATE ABORTION AND PREMATURE LABOUR.
    Wurm R
    Aust N Z J Obstet Gynaecol; 1963 Dec; 3(4):145-54. PubMed ID: 14102740
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of threatened abortion with a compound with a 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (Farlutal) base].
    GOISIS M; CAVALLI P; CANDOTTI G
    Minerva Ginecol; 1961 Sep; 13():903-5. PubMed ID: 13899588
    [No Abstract]   [Full Text] [Related]  

  • 13. HORMONAL MANAGEMENT OF THE FEMALE REPRODUCTIVE TRACT.
    RHOADES FP
    J Mich State Med Soc; 1963 Sep; 62():873-7. PubMed ID: 14048349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolonged amenorrhea after abortion during intensive treatment with progestagens].
    Pundel JP
    Gynecol Prat; 1971; 22(2):77-85. PubMed ID: 5562318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THE USE OF A PROGESTATIONAL SUBSTANCE IN CLINICAL PRACTICE].
    LAGOGR DO
    An Bras Ginecol; 1963 Jun; 55():329-36. PubMed ID: 14051286
    [No Abstract]   [Full Text] [Related]  

  • 16. MEDROXYPROGESTERONE TEST FOR DIAGNOSIS OF FIRST TRIMESTER PREGNANCY. A FIVE TABLET ORAL (SINGLE DOSE).
    WALTHER RA; PLATT WR
    Mo Med; 1964 Aug; 61():678-81. PubMed ID: 14180825
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal survival following threatened abortion.
    THOMPSON JF; LEIN JN
    Obstet Gynecol; 1961 Jul; 18():40-3. PubMed ID: 13776585
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECT OF PROVERA ON THE FETUS.
    BURSTEIN R; WASSERMAN HC
    Obstet Gynecol; 1964 Jun; 23():931-4. PubMed ID: 14168260
    [No Abstract]   [Full Text] [Related]  

  • 19. [FIBRINOLYTIC FACTOR IN THREATENED ABORTION].
    DEGENNARO F
    Minerva Ginecol; 1965 Jan; 17():28-33. PubMed ID: 14299803
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaginal cytology in spontaneous threatened abortion].
    MAYER MM; LEVASSEUR
    Ann Endocrinol (Paris); 1951; 12(4):540-3. PubMed ID: 14878225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.